This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Explore the key advantages of Zero Based Budgeting compared to Traditional Budgeting. Discover how this method can enhance your financial planning.
20,265 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
A major EV maker partners with Uber on a robotaxi plan, sending ripples through the market. This guide breaks down wh...
Figuring out what considered good stock dividends means looking beyond yield. This article breaks down the metrics th...
Morgan Stanley cuts Li Auto to a $22 price target while maintaining an upbeat view on margin recovery tied to the L9 ...
A Bay Area city mayor emerges as the lone pragmatic Democrat in California's governor race, drawing tech money and sp...
This deep-dive breaks down Saga's Q1 2026 earnings, what the results mean for guidance, and how investors can score 2...
Thinking beyond the U.S. market? This guide explains why ixus: this international stock can play a key role in divers...
As AI reshapes industries, investors want to know which supercycle stock will deliver the biggest gains. This guide b...
Warren Buffett’s Berkshire Hathaway more than triples its Alphabet stake to roughly $16.6 billion in the latest quart...
Meta Platforms delivered a powerful Q1 2026, with revenue surging and AI investment plans outlined, prompting investo...
Lucky To Live Here Realty is joining SERHANT.'s Long Island push, bringing a $1B+ track record to the brokerage. The ...
Pension funds are aggressively loading up on the Vanguard Intermediate-Term Government Bond ETF, a move that highligh...